Species-specific toxicity of aristolochic acid (AA) in vitro

Toxicology in Vitro

Volumn 22, Issue 5, 2008, Pages 1213-1221

  Huljic, S ^a   Bruske, E I ^a   Pfitzenmaier, N ^a   O'Brien, E ^a   Dietrich, D R ^a  

^a UNIVERSITY OF KONSTANZ   (Germany)

Author keywords

Aristolochic acid; Human; IHKE; Kidney; LLC PK1; NRK 52E; Pig; Primary culture; Rat

Indexed keywords

ARISTOLOCHIC ACID; DNA; THYMIDINE; TRITIUM;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL CYCLE; CELL LINE; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; DNA DAMAGE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY CORTEX; MALE; NONHUMAN; SENSITIVITY ANALYSIS; SPECIES DIFFERENCE;

ANIMALS; ARISTOLOCHIC ACIDS; CARCINOGENS; CELL CYCLE; CELL SURVIVAL; CELLS, CULTURED; DNA; DOSE-RESPONSE RELATIONSHIP, DRUG; EPITHELIAL CELLS; FORMAZANS; HUMANS; KIDNEY TUBULES, PROXIMAL; PREDICTIVE VALUE OF TESTS; RATS; SPECIES SPECIFICITY; SWINE; TETRAZOLIUM SALTS; THYMIDINE; TRITIUM;

RATTUS; RODENTIA; SUIDAE; SUS;

EID: 44749089097     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tiv.2008.04.002     Document Type: Article

References (43)

1. Arlt V.M., Schmeiser H.H., and Pfeifer G.P. Sequence-specific detection of aristolochic acid-DNA adducts in the human p53 gene by terminal transferase-dependent PCR. Carcinogenesis 22 1 (2001) 133-140
2. Bagetti Filho J.J.S., Pereira-Sampaio M.A., Favorito L.A., and Sampaio F.J.B. Pig kidney: anatomical relationships between the renal venous arrangement and the kidney collecting system. The Journal of Urology 179 (2008) 1627-1630
3. Balachandran P. Structure activity relationships of aristolochic acid analogues: toxicity in cultured renal epithelial cells. Kidney International 67 (2005) 1797-1805
4. Bieler C.A., Stiborova M., Wiessler M., Cosyns J.P., van Ypersele de Strihou C., and Schmeiser H.H. 32P-post-labelling analysis of DNA adducts formed by aristolochic acid in tissues from patients with Chinese herbs nephropathy. Carcinogenesis 18 5 (1997) 1063-1067
5. Birnboim H.C., and Jevcak J.J. Fluorometric method for rapid detection of DNA strand breaks in human white blood cells produced by low doses of radiation. Cancer Research 41 (1981) 1889-1892
6. Bruggeman I.M., Mertens J.J.W.M., Temmink J.H.M., Lans M.C., Vos R.M.E., and van Bladeren P.J. Use of monolayers or primary rat kidney cortex cells for nephrotoxicity Studies. Toxicology In Vitro 3 4 (1989) 261-269
7. Cosyns J.P., Jadoul M., Squifflet J.P., Wese F.X., and van Ypersele de Strihou C. Urothelial lesions in chinese-herb nephropathy. American Journal of Kidney Diseases 33 6 (1999) 1011-1017
8. Cummings B.S., Lasker J.M., and Lash L.H. Expression of glutathione-dependent enzymes and cytochrome P450s in freshly isolated and primary cultures of proximal tubular cells from human kidney. The Journal of Pharmacology and Experimental Therapeutics 293 2 (2000) 677-685
9. De Larco J.E., and Todaro G.J. Epithelioid and fibroblastic rat kidney cell clones: epidermal growth factor (EGF) receptors and the effect of mouse sarcoma virus transformation. Journal of Cellular Physiology 94 3 (1978) 335-342
10. Depierreux M., Van Damme B., Vanden Houte K., and Vanherweghem J.L. Pathologic aspects of a newly described nephropathy related to the prolonged use of Chinese herbs. American Journal of Kidney Diseases 24 2 (1994) 172-180
11. Dietrich D.R., O'Brien E., Stack M.E., and Heussner A.H. Species- and sex-specific renal cytotoxicity of ochratoxin A and B in vitro. Experimental and Toxicologic Pathology 53 2-3 (2001) 215-225
12. Gotzl E., and Schimmer O. Mutagenicity of aristolochic acids (I, II) and aristolic acid I in nuw YG strains in Salmonella typhimurium highly sensitive to certain mutagenic nitroarenes. Mutagenesis 8 1 (1993) 17-22
13. Goukassian D., Gad F., Yaar M., Eller M.S., Nehal U.S., and Gilchrest B.A. Mechanism and implications of the age-associated decrease in DNA repair capacity. The Journal of the Federation of American Societies for Experimental Biology 14 10 (2000) 1325-1334
14. Gstraunthaler G., Pfaller W., and Kotanko P. Biochemical characterization of renal epithelial cell cultures (LLC-PK1 and MDCK). American Journal of Physiology 248 4 Pt 2 (1985) F536-F544
15. Hazane F., Sauvaigo S., Douki T., Favier A., and Beani J.-C. Age-dependent DNA repair and cell cycle distribution of human skin fibroblasts in response to UVA irradiation. Journal of Photochemistry and Photobiology 82 3 (2006) 214-223
16. Hull R.N., Cherry W.R., and Weaver G.W. The origin and characteristics of a pig kidney cell strain, LLC-PK. In Vitro 12 10 (1976) 670-677
17. Kappes, F., Fahrer, J., Khodadoust, M.S., Tabbert, A., Strasser, C., Mor-Vaknin, N., Moreno-Villanueva, M., Buerkle, A., Markovitz, D.M., Ferrando, E., May, 2008. DEK is a poly(ADP-ribose)-acceptor in apoptosis and mediates resistance to genotoxic stress. Molecular and Cellular Biology, Epub adhead of print.
18. Lebeau C., Arlt V.M., Schmeiser H.H., Boom A., Verroust P.J., Devuyst O., and Beauwens R. Aristolochic acid impedes endocytosis and induces DNA adducts in proximal tubule cells. Kidney International 60 4 (2001) 1332-1342
19. Lebeau C., Debelle F.D., Arlt V.M., Pozdzik A., De Prez E.G., Phillips D.H., Deschodt-Lanckman M.M., Vanherweghem J.L., and Nortier J.L. Early proximal tubule injury in experimental aristolochic acid nephropathy: functional and histological studies. Nephrology Dialysis Transplantation 20 11 (2005) 2321-2332
20. Li Y., Liu Z., Guo X., Shu J., Chen Z., and Li L. Aristolochic acid I-induced DNA damage and cell cycle arrest in renal tubular epithelial cells in vitro. Archives of Toxicology 80 8 (2006) 524-532
21. Lord G.M., Hollstein M., Arlt V.M., Roufosse C., Pusey C.D., Cook T., and Schmeiser H.H. DNA adducts and p53 mutations in a patient with aristolochic acid-associated nephropathy. American Journal of Kidney Diseases 43 4 (2004) e11-e17
22. Maehle L., Metcalf R.A., Ryberg D., Bennett W.P., Harris C.C., and Haugen A. Altered p53 gene structure and expression in human epithelial cells after exposure to nickel. Cancer Research 52 1 (1992) 218-221
23. Mengs U. Acute toxicity of aristolochic acid in rodents. Archives of Toxicology 59 5 (1987) 328-331
24. Mengs U. Tumour induction in mice following exposure to aristolochic acid. Archives of Toxicology 61 6 (1988) 504-505
25. Mengs U., Lang W., and Poch J.-A. The carcinogenic action of aristolochic acid in Rats. Archives of Toxicology 51 (1982) 107-119
26. Moreno-Villanueva, M., 2008. Automatisierte Quantifizierung von DNA Schaedigung und DNA Reparatur und deren Anwendug in der genetischen Toxikologie und Alternsforschung. Department of Biology. Konstanz, University of Konstanz, p. 124.
27. Moreno-Villanueva M., Pfeiffer R., Mueller M., Leake A., Kirkwood T., Sindlinger T., and Buerkle A. An automated version of the fluorescence-detected alkine DNA-unwinding (FADU) assay to measure DNA strand breaks and DNA repair. Experimental Gerontology 42 (2007) 139-149
28. Nortier J. Urothelial carcinoma associated with the use of a chinese herb (aristolochia fangchi). The New England Journal of Medicine 342 23 (2000) 1686-1692
29. Nortier J., and Vanherweghem J.L. For patients taking herbal therapy - lessons from aristolochic acid nephropathy. Nephrology Dialysis Transplantation 22 6 (2007) 1512-1517
30. O'Brien E., Heussner A.H., and Dietrich D.R. Species-, sex-, and cell type-specific effects of ochratoxin A and B. Toxicological Sciences 63 2 (2001) 256-264
31. Pfeiffer, R., 2001. Development of Methods to Investigate Poly(ADP-ribose) Polymerase-1 Activity and DNA Base-Excision Repair in Relation to Cancer and Ageing. Department of pharmacy. Heidelberg, University of Heidelberg, p. 75.
32. Schmeiser H.H., Bieler C.A., Wiessler M., van Ypersele de Strihou C., and Cosyns J.P. Detection of DNA adducts formed by aristolochic acid in renal tissue from patients with Chinese herbs nephropathy. Cancer Research 56 9 (1996) 2025-2028
33. Schmeiser H.H., Frei E., Wiessler M., and Stiborova M. Comparison of DNA adduct formation by aristolochic acids in various in vitro activation systems by 32P-post-labelling: evidence for reductive activation by peroxidases. Carcinogenesis 18 5 (1997) 1055-1062
34. Schmucker D.L., and Wang R.K. Age-related changes in liver drug-metabolizing enzymes. Experimental Gerontology 15 5 (1980) 321-329
35. Soucek P., Zuber R., Anzenbacherova E., Anzenbacher P., and Guengerich F.P. Minipig cytochrome P450 3A, 2A and 2C enzymes have similar properties to human analogs. BMC Pharmacology 1 11 (2001)
36. Stiborova M., Frei E., Sopko B., Sopkova K., Markova V., Lankova M., Kumstyrova T., Wiessler M., and Schmeiser H.H. Human cytosolic enzymes involved in the metabolic activation of carcinogenic aristolochic acid: evidence for reductive activation by human NAD(P)H:quinone oxidoreductase. Carcinogenesis 24 10 (2003) 1695-1703
37. Stiborova M., Frei E., Wiessler M., and Schmeiser H.H. Human enzymes involved in the metabolic activation of carcinogenic aristolochic acids: evidence for reductive activation by cytochromes P450 1A1 and 1A2. Chemical Research in Toxicology 14 8 (2001) 1128-1137
38. Terris J.M. Swine in Biochemical Research (1986), Plenum Press, New York
39. Tveito G., Hansteen I.L., Dalen H., and Haugen A. Immortalization of normal human kidney epithelial cells by nickel(II). Cancer Research 49 7 (1989) 1829-1835
40. Vanherweghem J.L., Tielemans C., Simon J., and Depierreux M. Chinese herbs nephropathy and renal pelvic carcinoma. Nephrology Dialysis Transplantation 10 2 (1995) 270-273
41. Warrington J.S., Greenblatt D.J., and Von Moltke L.L. Age-related differences in CYP3A expression and activity in the rat liver, intestine, and kidney. The Journal of Pharmacology and Experimental Therapeutics 309 2 (2004) 720-729
42. Wilkening S., Stahl F., and Bader A. Comparison of primary human hepatocytes and hepatoma cell line Hepg2 with regard to their biotransformation properties. Drug Metabolism and Disposition 31 8 (2003) 1035-1042
43. Zhang H., Cifone M.A., Murli H., Erexson G.L., Mecchi M.S., and Lawlor T.E. Application of simplified in vitro screening tests to detect genotoxicity of aristolochic acid. Food and Chemical Toxicology 42 12 (2004) 2021-2028